Canada Graves’ disease market is growing at a CAGR of around 6.3% during the forecast period. Due to increasing awareness of thyroid disease in the country by various government organizations, the Canada Graves’ disease market is expected to grow. For instance, June is celebrated as thyroid awareness month in Canada. The Thyroid Foundation of Canada (TFC), a non-profit organization established in 1980 with the objective of supporting patients suffering from thyroid disease. The foundation has given nearly $1 million for researches on thyroid disease. This funding supports in researches on thyroid disease.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/canada-graves-disease-market

As Grave’s is the most common autoimmune thyroid disease, this may result in a significant rise in researches for discovering effective medication for patients. Moreover, according to TFC, Grave’s disease is by far the most common cause of hyperthyroidism in Canada. Grave’s disease affects nearly one in every 100 people in Canada, which in turn creates significant scope for the growth of Canada Graves’ disease market.

A full report of Canada Graves’ Disease Market is available at: https://www.omrglobal.com/industry-reports/canada-graves-disease-market

Further, a significant number of smokers in Canada are also a major cause of Grave’s disease in Canada. According to Statistics Canada, in 2017, 16.2% of Canadians aged 12 and over, which is nearly 5 million people smoked either daily or occasionally. Of the 5 million current smokers, 3.6 million smoked cigarettes every day. According to the British Thyroid Foundation, Cigarette smoking is identified to have a key influence on Grave’s disease and on thyroid eye disease (TED).

Smoking can lead to Grave’s disease as it consists of thousands of chemicals and among which some can stimulate the immune system for reacting against the thyroid. Moreover, smokers with Grave’s disease are nearly two times more expected to develop TED. This represents the relation of smoking with Grave’s disease and thereby results in the adoption of anti-thyroid medication for the treatment of the condition, which in turn positively affects the Canada Graves’ disease market growth.

Canada Graves’ Disease Market – Segmentation

by Diagnosis

• Ultrasound
• Imaging Tests
• Radioactive Iodine Uptake
• Blood Sample

by Treatment

• Anti- Thyroid Medication
• Radioactive Iodine Therapy
• Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/canada-graves-disease-market

Company Profiles

• Abbott Laboratories Inc.
• Allergan PLC
• Eli Lilly and Co.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Macleods Pharmaceuticals Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis International AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404